LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Basel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic ...

He started his career with Infosys BPM., where he worked for its clients BNY Mellon and Deutsche Bank. Later, he worked with various investors, research companies, and investment firms like Tech ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational ...